@graham15
Specifically, our resident researcher/sherlock @pfeifer1982 did a great post on the GvHD differences between CYP and MSB
https://hotcopper.com.au/threads/ann-product-development-program-update-investor-presentation.4267746/page-5?post_id=33968577
"On day 100 -
MSB injected 1.92 billion cells
Cynata injected between 160 mio cells (lower dose - 1/12 of MSB's) and 320 mio cells (higher dose - 1/6 of MSB's)!"
Cymerus for GvHD so far is miles ahead in numbers of cells required and amount of times the patient will need to be dosed.
This WILL lead to a cheaper product that is less invasive for patients.
MSB also bought their GvHD treatment, their only product for sale was developed by another company, Osiris, who they will pay $ to, just like Fuji to CYP.
They have yet to develop their own commercial product from scratch.
2020 - A Year Full Of Potentials, page-223
-
- There are more pages in this discussion • 285 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 24.0¢ | $23.56K | 97.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18606 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |